Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι

Metabolism: Clinical and Experimental

Volumn 61, Issue 4, 2012, Pages 459-469

  Sajan, Mini P ^a   Nimal, Sonali ^b   Mastorides, Stephen ^a   Acevedo Duncan, Mildred ^a   Kahn, C Ronald ^c   Fields, Alan P ^d   Braun, Ursula ^e   Leitges, Michael ^e   Farese, Robert V ^a,b,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ROSKAMP INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H IMIDAZOLE 4 CARBOXAMIDE; 5 AMINO 1 [2,3 DIHYDROXY 4[(PHOSPHONO OXY)METHYL]CYCLOPENTYL [1R (1A,2B,3B,4A)]; AUROTHIOMALATE; INSULIN; PROTEIN KINASE B; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; FATTY LIVER; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; KNOCKOUT MOUSE; MALE; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; INSULIN; ISOENZYMES; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; OBESITY; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84858439965     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.12.008     Document Type: Article

References (18)

1. M.L. Standaert, M.P. Sajan, and A. Mirua Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic ob/ob and Goto-Kakizaki liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states J Biol Chem 279 2004 24929 24934 (Pubitemid 38756740)
2. M.P. Sajan, M.L. Standaert, and S. Nimal Critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFκB in obesity J Lipid Res 50 2009 1133 1145
3. M.P. Sajan, M.L. Standaert, and J. Rivas Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as model of diabetes, and relationships to hyperlipidaemia and insulin resistance Diabetologia 52 2009 1197 1207
4. A.M. Valverde, D.J. Burks, and I. Fabregat Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes Diabetes 52 2003 2239 2248 (Pubitemid 37059493)
5. K. Ueki, T. Yamauchi, and H. Tamemoto Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy J Clin Invest 105 2000 1437 1445 (Pubitemid 30322409)
6. M.P. Sajan, M.L. Standaert, and A. Miura Tissue-specific differences in activation of atypical protein kinase C and protein kinase B in muscle, liver and adipocytes of insulin receptor substrate-1 knockout mice Mol Endocrinol 18 2004 2513 2521 (Pubitemid 39335985)
7. S. Guo, K.D. Copps, and S. Park The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis Mol Cell Biol 29 2009 5070 5083
8. R.V. Farese, and M.P. Sajan Metabolic functions of atypical protein kinase C: "good and bad" as defined by nutritional status (invited review) Am J Physiol Endocrinol Metab 298 2010 E385 E394
9. M. Matsumoto, W. Ogawa, and K. Akimoto PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity J Clin Invest 112 2003 935 944 (Pubitemid 38063751)
10. R.V. Farese, M.P. Sajan, H. Yang, P. Li, S. Mastorides, and W. Gower Muscle-specific knockout of protein kinase C-λ impairs glucose transport and induces metabolic and diabetic syndromes J Clin Invest 117 2007 2289 2301 (Pubitemid 47219574)
11. P. Pillai, S. Desai, and R. Patel ICA-1: a novel PKC-ι inhibitor that abrogates cell proliferation and induces apoptosis in neuroblastoma Internat J Biochem and Cell Biol 43 2011 784 794
12. M. Stallings-Mann, L. Jamieson, and R.P. Regala A novel small molecule inhibitor of protein kinase Cι blocks transformed growth of non-small cell lung cancer Cancer Res 66 2006 1767 1774 (Pubitemid 43259962)
13. E. Erdogan, T. Lamark, and M. Stallings-Mann Aurothiomalate inhibits transformed growth by targeting the PB1 domain of atypical protein kinase Ciota J Biol Chem 281 2006 28450 28459 (Pubitemid 44414558)
14. A.P. Fields, L.A. Frederick, and R.P. Regala Targeting the oncogenic protein kinase Ciota for the treatment of cancer Biochem Soc Trans 23 2007 1996 2000
15. R.P. Regala, E.A. Thompson, and A.P. Fields Atypical protein kinase Cι expression and aurothiomalate sensitivity in human lung cancer cells Cancer Res 68 2008 5888 5895
16. 3 is defective in muscle in type 2 diabetes and impaired glucose intolerance. Amelioration by rosiglitazone and exercise Diabetes 52 2003 1926 1934 (Pubitemid 36919783)
17. J.P. Thaler, S.J. Choi, and M.P. Sajan Atypical protein kinase C activity in the hypothalamus is required for lipopolysaccharide-mediated sickness responses Endocrinol 150 2009 5362 5372 2009
18. Y.B. Kim, K. Kotani, and T.P. Ciaraldi Insulin-stimulated protein kinase C-λ/ζ activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes; reversal with weight reduction Diabetes 52 2003 1935 1942 (Pubitemid 36919784)